BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 34186536)

  • 1. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    Sato K; Mano T; Ihara R; Suzuki K; Tomita N; Arai H; Ishii K; Senda M; Ito K; Ikeuchi T; Kuwano R; Matsuda H; Iwatsubo T; Toda T; Iwata A;
    J Alzheimers Dis; 2019; 68(2):777-788. PubMed ID: 30814351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.
    Bondi MW; Edmonds EC; Jak AJ; Clark LR; Delano-Wood L; McDonald CR; Nation DA; Libon DJ; Au R; Galasko D; Salmon DP
    J Alzheimers Dis; 2014; 42(1):275-89. PubMed ID: 24844687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ontology-based approach for harmonization and cross-cohort query of Alzheimer's disease data resources.
    Hao X; Li X; Zhang GQ; Tao C; Schulz PE; ; Cui L
    BMC Med Inform Decis Mak; 2023 Aug; 23(Suppl 1):151. PubMed ID: 37542312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subscale validation of the neuropsychiatric inventory questionnaire: comparison of Alzheimer's disease neuroimaging initiative and national Alzheimer's coordinating center cohorts.
    Trzepacz PT; Saykin A; Yu P; Bhamditipati P; Sun J; Dennehy EB; Willis B; Cummings JL;
    Am J Geriatr Psychiatry; 2013 Jul; 21(7):607-22. PubMed ID: 23602309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Harnessing forgetfulness: can episodic-memory tests predict early Alzheimer's disease?
    Warren SL; Moustafa AA; Alashwal H;
    Exp Brain Res; 2021 Sep; 239(9):2925-2937. PubMed ID: 34313791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
    Fan L; Borenstein AR; Wang S; Nho K; Zhu X; Wen W; Huang X; Mortimer JA; Shrubsole MJ; Dai Q;
    EBioMedicine; 2023 Nov; 97():104818. PubMed ID: 37793213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Implications of Slowing Disease Progression in Amyloid-Positive Early Alzheimer's Disease: Estimates from Real-World Data.
    Chandler J; Done N; Desai U; Georgieva M; Gomez-Lievano A; Ye W; Zhao A; Eid D; Hilts A; Kirson N; Schilling T
    J Prev Alzheimers Dis; 2024; 11(2):310-319. PubMed ID: 38374737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
    Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
    Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
    Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
    Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    Wada M; Noda Y; Shinagawa S; Chung JK; Sawada K; Ogyu K; Tarumi R; Tsugawa S; Miyazaki T; Yamagata B; Graff-Guerrero A; Mimura M; Nakajima S;
    J Alzheimers Dis; 2018; 63(2):861-869. PubMed ID: 29689728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MCI-to-normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative.
    Thomas KR; Edmonds EC; Eppig JS; Wong CG; Weigand AJ; Bangen KJ; Jak AJ; Delano-Wood L; Galasko DR; Salmon DP; Edland SD; Bondi MW;
    Alzheimers Dement; 2019 Oct; 15(10):1322-1332. PubMed ID: 31495605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting mild cognitive impairment in older adults: A machine learning analysis of the Alzheimer's Disease Neuroimaging Initiative.
    Wu Y; Wang X; Fang Y
    Geriatr Gerontol Int; 2024 Mar; 24 Suppl 1():96-101. PubMed ID: 37734954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.
    Graves LV; Edmonds EC; Thomas KR; Weigand AJ; Cooper S; Bondi MW
    J Alzheimers Dis; 2020; 78(1):371-386. PubMed ID: 32986674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data-driven classification of cognitively normal and mild cognitive impairment subtypes predicts progression in the NACC dataset.
    Edmonds EC; Thomas KR; Rapcsak SZ; Lindemer SL; Delano-Wood L; Salmon DP; Bondi MW
    Alzheimers Dement; 2024 May; 20(5):3442-3454. PubMed ID: 38574399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease severity and mortality in Alzheimer's disease: an analysis using the U.S. National Alzheimer's Coordinating Center Uniform Data Set.
    Crowell V; Reyes A; Zhou SQ; Vassilaki M; Gsteiger S; Gustavsson A
    BMC Neurol; 2023 Aug; 23(1):302. PubMed ID: 37580727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOE ε4 positivity predicts centrality of episodic memory nodes in patients with mild cognitive impairment: A cohort-based, graph theory-informed study of cognitive networks.
    De Marco M; Wright LM; Valera Bermejo JM; Ferguson CE
    Neuropsychologia; 2024 Jan; 192():108741. PubMed ID: 38040087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Association Between Epigenetic Aging-Acceleration and the Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    Liu H; Lutz M; Luo S;
    J Gerontol A Biol Sci Med Sci; 2022 Sep; 77(9):1734-1742. PubMed ID: 35797594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.